KNSA

Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year · Ends Dec 30, 19:00 ET

Black Friday $299.50 → $149.00 Ends Dec 30, 19:00 ET Black Friday $299.50 → $149.00 Ends Dec 30, 19:00 ET Black Friday $299.50 → $149.00 Ends Dec 30, 19:00 ET Black Friday $299.50 → $149.00 Ends Dec 30, 19:00 ET Black Friday $299.50 → $149.00 Ends Dec 30, 19:00 ET

Peers: CRDL BCRX ALKS CYTK MIRM KRYS ARGX REGN PTCT ACAD

| Held by: IWM VTI VB IWO VBK DFAS VTWO DFAC PSC VHT

Scroll to Statements

Index	RUT
Market Cap	7.47B
Enterprise Value	6.91B
Income	109.57M
Sales	945.96M
Book/sh	9.05
Cash/sh	7.24
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	366
IPO	May 24, 2018

P/E	72.50
Forward P/E	46.91
PEG	0.84
P/S	7.89
P/B	10.50
P/C	13.13
P/FCF	37.86
EV/EBITDA	52.17
EV/Sales	7.30
Quick Ratio	3.35
Current Ratio	3.91
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	1.31
EPS next Y	2.03
EPS next Q	0.25
EPS this Y	97.88%
EPS next Y	36.47%
EPS next 5Y	55.96%
EPS past 3/5Y	-34.04% -
Sales past 3/5Y	45.45% -
EPS Y/Y TTM	192.34%
Sales Y/Y TTM	58.19%
EPS Q/Q	142.08%
Sales Q/Q	58.12%
Earnings	Oct 27 BMO
EPS/Sales Surpr.	50.94% 9.71%

Insider Own	42.05%
Insider Trans	-2.46%
Inst Own	59.86%
Inst Trans	2.44%
ROA	12.92%
ROE	17.59%
ROIC	15.34%
Gross Margin	54.21%
Oper. Margin	13.79%
Profit Margin	11.58%
SMA20	9.18%
SMA50	17.02%
SMA200	53.14%
Trades

Shs Outstand	48.75M
Shs Float	45.53M
Short Float	9.43%
Short Ratio	6.48
Short Interest	4.29M
52W High	99.31 -4.32%
52W Low	37.02 156.67%
Volatility	6.43% 5.58%
ATR (14)	5.06
RSI (14)	58.94
Beta	0.08
Rel Volume	0.00
Avg Volume	662.87K
Volume	0

Perf Week	1.85%
Perf Month	19.91%
Perf Quarter	21.59%
Perf Half Y	59.75%
Perf YTD	130.35%
Perf Year	140.56%
Perf 3Y	558.03%
Perf 5Y	592.57%
Perf 10Y	-
Recom	1.00
Target Price	109.43
Prev Close	95.02
Price	95.02
Change %	0.00%

All the Features.Half the Price.

Kiniksa Pharmaceuticals International Plc

Upgrade your Finviz experience

All the Features.
Half the Price.